Neurocrine Biosciences | NBIX - Empleados Numero total





Empleados Cambio Fecha
AbbVie 55K 5K 2024-12
Acadia Pharmaceuticals 653 56 2024-12
Agios Pharmaceuticals 486 103 2024-12
ALKERMES 1.8K 300 2024-12
Alnylam Pharmaceuticals 2.23K 130 2024-12
Amgen 28K 1.3K 2024-12
Biogen 7.6K 35 2024-12
BioMarin Pharmaceutical 3.04K 361 2024-12
Cytokinetics 498 75 2024-12
Enanta Pharmaceuticals 145 15 2023-09
Exelixis 1.15K 163 2025-12
Gilead Sciences 17.6K 400 2024-12
Halozyme Therapeutics 350 23 2024-12
Incyte 2.62K 93 2024-12
Ionis Pharmaceuticals 1.07K 142 2024-12
Nektar Therapeutics 137 79 2023-12
Neurocrine Biosciences 1.8K 400 2024-12
Pfizer 81K 7K 2024-12
Prothena 163 10 2024-12
Regeneron Pharmaceuticals 13.45K 1.6K 2023-12
Repligen 1.78K 5 2024-12
Rigel Pharmaceuticals 147 8 2023-12
Sarepta Therapeutics 1.37K 58 2024-12
Ultragenyx Pharmaceutical 1.29K 18 2024-12
Vertex Pharmaceuticals 6.1K 700 2024-12
Xoma 13 1 2023-12